{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:52:44Z","timestamp":1792709564099,"version":"4.5.0"},"reference-count":126,"publisher":"Elsevier BV","issue":"47","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,8,29]],"date-time":"2010-08-29T00:00:00Z","timestamp":1283040000000},"content-version":"vor","delay-in-days":301,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.vaccine.2009.08.044","type":"journal-article","created":{"date-parts":[[2009,8,30]],"date-time":"2009-08-30T04:09:29Z","timestamp":1251605369000},"page":"6495-6503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Recombinant Mycobacterium bovis BCG"],"prefix":"10.1016","volume":"27","author":[{"given":"Reginaldo G.","family":"Bastos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibele","family":"Borsuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana K.","family":"Seixas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odir A.","family":"Dellagostin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2009.08.044_bib1","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1128\/jb.178.5.1274-1282.1996","article-title":"Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis","volume":"178","author":"Mahairas","year":"1996","journal-title":"J Bacteriol"},{"issue":"5419","key":"10.1016\/j.vaccine.2009.08.044_bib2","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1126\/science.284.5419.1520","article-title":"Comparative genomics of BCG vaccines by whole-genome DNA microarray","volume":"284","author":"Behr","year":"1999","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.vaccine.2009.08.044_bib3","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0966-842X(01)02131-X","article-title":"The evolution of mycobacterial pathogenicity: clues from comparative genomics","volume":"9","author":"Brosch","year":"2001","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2009.08.044_bib4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/1471-2164-9-413","article-title":"Novel genome polymorphisms in BCG vaccine strains and impact on efficacy","volume":"9","author":"Leung","year":"2008","journal-title":"BMC Genomics"},{"issue":"5","key":"10.1016\/j.vaccine.2009.08.044_bib5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0962-8479(92)90129-8","article-title":"Theoretical and methodological aspects of BCG vaccine from the discovery of Calmette and Guerin to molecular biology. A review","volume":"73","author":"Lugosi","year":"1992","journal-title":"Tuber Lung Dis"},{"key":"10.1016\/j.vaccine.2009.08.044_bib6","series-title":"Tuberculosis: Pathogenesis, Protection, and Control","first-page":"531","article-title":"The BCG experience: implications for future vaccines against tuberculosis","author":"Bloom","year":"1994"},{"key":"10.1016\/j.vaccine.2009.08.044_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1749-6632.1989.tb27366.x","article-title":"New strategies for leprosy and tuberculosis and for development of bacillus Calmette\u2013Guerin into a multivaccine vehicle","volume":"569","author":"Bloom","year":"1989","journal-title":"Ann N Y Acad Sci"},{"issue":"6326","key":"10.1016\/j.vaccine.2009.08.044_bib8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/351456a0","article-title":"New use of BCG for recombinant vaccines","volume":"351","author":"Stover","year":"1991","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.vaccine.2009.08.044_bib9","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/elps.1150190418","article-title":"Mycobacterial genome structure","volume":"19","author":"Philipp","year":"1998","journal-title":"Electrophoresis"},{"key":"10.1016\/j.vaccine.2009.08.044_bib10","series-title":"Tuberculosis: Pathogenesis, Protection, and Control","first-page":"398","article-title":"Immune mechanism of protection","author":"Chan","year":"1994"},{"key":"10.1016\/j.vaccine.2009.08.044_bib11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.iy.10.040192.002321","article-title":"Stigma variations: observations on suppressor T cells and leprosy","volume":"10","author":"Bloom","year":"1992","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.08.044_bib12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1084\/jem.193.3.271","article-title":"The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice","volume":"193","author":"Mogues","year":"2001","journal-title":"J Exp Med"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2009.08.044_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0264-410X(02)00447-4","article-title":"A novel TB vaccine; towards a strategy based on our understanding of BCG failure","volume":"21","author":"Agger","year":"2002","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2009.08.044_bib14","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.vaccine.2004.08.039","article-title":"Factors influencing the immune response to foreign antigen expressed in recombinant BCG vaccines","volume":"23","author":"Dennehy","year":"2005","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2009.08.044_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.tube.2004.10.004","article-title":"A new vaccine against tuberculosis shows greater protection in a mouse model with progressive pulmonary tuberculosis","volume":"85","author":"Castanon-Arreola","year":"2005","journal-title":"Tuberculosis (Edinb)"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2009.08.044_bib16","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.micinf.2005.04.002","article-title":"Recombinant BCG expressing Mycobacterium tuberculosis major extracellular proteins","volume":"7","author":"Horwitz","year":"2005","journal-title":"Microbes Infect"},{"issue":"6122","key":"10.1016\/j.vaccine.2009.08.044_bib17","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/327532a0","article-title":"Introduction of foreign DNA into mycobacteria using a shuttle phasmid","volume":"327","author":"Jacobs","year":"1987","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.vaccine.2009.08.044_bib18","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.1073\/pnas.85.18.6987","article-title":"Lysogeny and transformation in mycobacteria: stable expression of foreign genes","volume":"85","author":"Snapper","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.vaccine.2009.08.044_bib19","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1128\/iai.58.12.4049-4054.1990","article-title":"Establishment of a foreign antigen secretion system in mycobacteria","volume":"58","author":"Matsuo","year":"1990","journal-title":"Infect Immun"},{"issue":"Pt 8","key":"10.1016\/j.vaccine.2009.08.044_bib20","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1099\/13500872-141-8-1785","article-title":"Activity of mycobacterial promoters during intracellular and extracellular growth","volume":"141","author":"Dellagostin","year":"1995","journal-title":"Microbiology"},{"issue":"2","key":"10.1016\/j.vaccine.2009.08.044_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0769-2609(85)80045-4","article-title":"Restriction endonuclease mapping and cloning of Mycobacterium fortuitum var. fortuitum plasmid pAL5000","volume":"136B","author":"Labidi","year":"1985","journal-title":"Ann Inst Pasteur Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.044_bib22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1128\/IAI.70.1.303-314.2002","article-title":"Plasmidic versus insertional cloning of heterologous genes in Mycobacterium bovis BCG: impact on in vivo antigen persistence and immune responses","volume":"70","author":"Mederle","year":"2002","journal-title":"Infect Immun"},{"issue":"6326","key":"10.1016\/j.vaccine.2009.08.044_bib23","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/351479a0","article-title":"Humoral and cell-mediated immune responses to live recombinant BCG\u2013HIV vaccines","volume":"351","author":"Aldovini","year":"1991","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.vaccine.2009.08.044_bib24","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1111\/j.1365-2958.1992.tb02201.x","article-title":"Expression of Escherichia coli beta-galactosidase in Mycobacterium bovis BCG using an expression system isolated from Mycobacterium paratuberculosis which induced humoral and cellular immune responses","volume":"6","author":"Murray","year":"1992","journal-title":"Mol Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.044_bib25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1084\/jem.178.1.197","article-title":"Protective immunity elicited by recombinant bacille Calmette\u2013Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine","volume":"178","author":"Stover","year":"1993","journal-title":"J Exp Med"},{"issue":"21","key":"10.1016\/j.vaccine.2009.08.044_bib26","doi-asserted-by":"crossref","first-page":"6749","DOI":"10.1128\/jb.176.21.6749-6753.1994","article-title":"Escherichia coli-mycobacteria shuttle vectors for operon and gene fusions to lacZ: the pJEM series","volume":"176","author":"Timm","year":"1994","journal-title":"J Bacteriol"},{"issue":"6506","key":"10.1016\/j.vaccine.2009.08.044_bib27","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/372552a0","article-title":"Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi","volume":"372","author":"Langermann","year":"1994","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.vaccine.2009.08.044_bib28","doi-asserted-by":"crossref","first-page":"8716","DOI":"10.1128\/JVI.79.14.8716-8723.2005","article-title":"Mycobacterial codon optimization enhances antigen expression and virus-specific immune responses in recombinant Mycobacterium bovis bacille Calmette\u2013Guerin expressing human immunodeficiency virus type 1 Gag","volume":"79","author":"Kanekiyo","year":"2005","journal-title":"J Virol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2009.08.044_bib29","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0264-410X(03)00572-3","article-title":"Immune response of pigs inoculated with Mycobacterium bovis BCG expressing a truncated form of GP5 and M protein of porcine reproductive and respiratory syndrome virus","volume":"22","author":"Bastos","year":"2004","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2009.08.044_bib30","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1128\/IAI.72.6.3336-3343.2004","article-title":"Recombinant Mycobacterium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge","volume":"72","author":"Varaldo","year":"2004","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2009.08.044_bib31","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1365-2958.1993.tb00970.x","article-title":"Construction and use of integrative vectors to express foreign genes in mycobacteria","volume":"10","author":"Dellagostin","year":"1993","journal-title":"Mol Microbiol"},{"issue":"37\u201339","key":"10.1016\/j.vaccine.2009.08.044_bib32","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.1016\/j.vaccine.2006.05.028","article-title":"Immunogenicity of Mycobacterium bovis BCG expressing Anaplasma marginale MSP1a antigen","volume":"24","author":"Michelon","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2009.08.044_bib33","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1139\/w06-138","article-title":"Evaluation of different ways of presenting LipL32 to the immune system with the aim of developing a recombinant vaccine against leptospirosis","volume":"53","author":"Seixas","year":"2007","journal-title":"Can J Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.044_bib34","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.vaccine.2007.10.052","article-title":"Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge","volume":"26","author":"Seixas","year":"2007","journal-title":"Vaccine"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2009.08.044_bib35","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0923-2508(90)90132-A","article-title":"Recombinant BCG as a candidate oral vaccine vector","volume":"141","author":"Barletta","year":"1990","journal-title":"Res Microbiol"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2009.08.044_bib36","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0264-410X(98)00350-8","article-title":"Construction and murine immunogenicity of recombinant Bacille Calmette Guerin vaccines expressing the B subunit of Escherichia coli heat labile enterotoxin","volume":"17","author":"Hayward","year":"1999","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2009.08.044_bib37","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1006\/clim.2002.5292","article-title":"Oral recombinant Mycobacterium bovis bacillus Calmette\u2013Guerin expressing HIV-1 antigens as a freeze-dried vaccine induces long-term, HIV-specific mucosal and systemic immunity","volume":"105","author":"Kawahara","year":"2002","journal-title":"Clin Immunol"},{"issue":"27\u201330","key":"10.1016\/j.vaccine.2009.08.044_bib38","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1016\/S0264-410X(03)00537-1","article-title":"Mucosal administration of three recombinant Mycobacterium bovis BCG-SIVmac251 strains to cynomolgus macaques induces rectal IgAs and boosts systemic cellular immune responses that are primed by intradermal vaccination","volume":"21","author":"Mederle","year":"2003","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2009.08.044_bib39","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1128\/IAI.66.12.5743-5750.1998","article-title":"Mycobacterial dose defines the Th1\/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route","volume":"66","author":"Power","year":"1998","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2009.08.044_bib40","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nm859","article-title":"Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis","volume":"9","author":"Pym","year":"2003","journal-title":"Nat Med"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2009.08.044_bib41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0264-410X(02)00443-7","article-title":"Construction and immunogenicity of recombinant Mycobacterium bovis BCG expressing GP5 and M protein of porcine reproductive respiratory syndrome virus","volume":"21","author":"Bastos","year":"2002","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2009.08.044_bib42","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1084\/jem.180.6.2277","article-title":"Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette\u2013Guerin vaccines expressing pneumococcal surface protein A","volume":"180","author":"Langermann","year":"1994","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.044_bib43","first-page":"62","article-title":"Recent advances in the development of live, attenuated bacterial vectors","volume":"7","author":"Roland","year":"2005","journal-title":"Curr Opin Mol Ther"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2009.08.044_bib44","first-page":"939","article-title":"Improved protection by recombinant BCG","volume":"7","author":"Nasser","year":"2005","journal-title":"Microbes Infect"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2009.08.044_bib45","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0264-410X(98)00276-X","article-title":"Safety and immunogenicity of recombinant Bacille Calmette\u2013Guerin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine","volume":"17","author":"Edelman","year":"1999","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.044_bib46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/expr.1999.4459","article-title":"BCG expressing LCR1 of Leishmania chagasi induces protective immunity in susceptible mice","volume":"94","author":"Streit","year":"2000","journal-title":"Exp Parasitol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.08.044_bib47","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/j.vaccine.2005.11.029","article-title":"Immunisation with recombinant BCG expressing the cottontail rabbit papillomavirus (CRPV) L1 gene provides protection from CRPV challenge","volume":"24","author":"Govan","year":"2006","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2009.08.044_bib48","doi-asserted-by":"crossref","first-page":"5100","DOI":"10.1128\/IAI.67.10.5100-5105.1999","article-title":"Humoral and cellular immune responses in mice immunized with recombinant Mycobacterium bovis Bacillus Calmette\u2013Guerin producing a pertussis toxin-tetanus toxin hybrid protein","volume":"67","author":"Abomoelak","year":"1999","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.044_bib49","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1006\/viro.1999.0131","article-title":"The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins","volume":"268","author":"Leung","year":"2000","journal-title":"Virology"},{"issue":"Pt 7","key":"10.1016\/j.vaccine.2009.08.044_bib50","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1099\/00221287-148-7-1999","article-title":"Comparative evaluation of Mycobacterium vaccae as a surrogate cloning host for use in the study of mycobacterial genetics","volume":"148","author":"Medeiros","year":"2002","journal-title":"Microbiology"},{"issue":"6","key":"10.1016\/j.vaccine.2009.08.044_bib51","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.tube.2007.07.006","article-title":"Auxotrophic complementation as a selectable marker for stable expression of foreign antigens in Mycobacterium bovis BCG","volume":"87","author":"Borsuk","year":"2007","journal-title":"Tuberculosis (Edinb)"},{"issue":"2","key":"10.1016\/j.vaccine.2009.08.044_bib52","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1073\/pnas.93.2.934","article-title":"Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette\u2013Guerin strains that secrete cytokines","volume":"93","author":"Murray","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.vaccine.2009.08.044_bib53","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0022-5347(17)42722-4","article-title":"Results of 6 weekly intravesical bacillus Calmette\u2013Guerin instillations on the treatment of superficial bladder tumors","volume":"139","author":"Kavoussi","year":"1988","journal-title":"J Urol"},{"issue":"9165","key":"10.1016\/j.vaccine.2009.08.044_bib54","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0140-6736(98)07422-4","article-title":"BCG immunotherapy of bladder cancer: 20 years on","volume":"353","author":"Alexandroff","year":"1999","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2009.08.044_bib55","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1128\/iai.62.6.2508-2514.1994","article-title":"Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes","volume":"62","author":"O\u2019Donnell","year":"1994","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2009.08.044_bib56","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/intimm\/dxf050","article-title":"IL-2-secreting recombinant bacillus Calmette Guerin can overcome a Type 2 immune response and corticosteroid-induced immunosuppression to elicit a Type 1 immune response","volume":"14","author":"Young","year":"2002","journal-title":"Int Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.08.044_bib57","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1128\/IAI.70.12.6549-6557.2002","article-title":"Mycobacterium bovis BCG producing interleukin-18 increases antigen-specific gamma interferon production in mice","volume":"70","author":"Biet","year":"2002","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.044_bib58","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2249.2004.02522.x","article-title":"Recombinant Mycobacterium bovis bacillus Calmette\u2013Guerin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity","volume":"137","author":"Luo","year":"2004","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.044_bib59","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1046\/j.1365-2249.2000.01100.x","article-title":"Bacille Calmette\u2013Guerin (BCG)-associated inflammation and fibrosis: modulation by recombinant BCG expressing interferon-gamma (IFN-gamma)","volume":"119","author":"Wangoo","year":"2000","journal-title":"Clin Exp Immunol"},{"issue":"25","key":"10.1016\/j.vaccine.2009.08.044_bib60","doi-asserted-by":"crossref","first-page":"13853","DOI":"10.1073\/pnas.250480397","article-title":"Recombinant bacillus Calmette\u2013Guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model","volume":"97","author":"Horwitz","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.vaccine.2009.08.044_bib61","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1086\/592450","article-title":"A new recombinant bacille Calmette\u2013Guerin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers","volume":"198","author":"Hoft","year":"2008","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.044_bib62","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00430-002-0170-x","article-title":"Immunogenicity of recombinant BCG vaccine strains overexpressing components of the antigen 85 complex of Mycobacterium tuberculosis","volume":"193","author":"Dhar","year":"2004","journal-title":"Med Microbiol Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.08.044_bib63","doi-asserted-by":"crossref","first-page":"e3869","DOI":"10.1371\/journal.pone.0003869","article-title":"Enhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lung","volume":"3","author":"Jain","year":"2008","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.vaccine.2009.08.044_bib64","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.tube.2007.06.002","article-title":"Recombinant BCG Tokyo (Ag85A) protects cynomolgus monkeys (Macaca fascicularis) infected with H37Rv Mycobacterium tuberculosis","volume":"87","author":"Sugawara","year":"2007","journal-title":"Tuberculosis (Edinb)"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.044_bib65","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tube.2008.09.008","article-title":"Protective efficacy of recombinant BCG Tokyo (Ag85A) in rhesus monkeys (Macaca mulatta) infected intratracheally with H37Rv Mycobacterium tuberculosis","volume":"89","author":"Sugawara","year":"2009","journal-title":"Tuberculosis (Edinb)"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.044_bib66","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.vaccine.2008.10.034","article-title":"Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells","volume":"27","author":"Badell","year":"2009","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2009.08.044_bib67","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1745-7270.2007.00281.x","article-title":"Immune responses and protective efficacy induced by 85B antigen and early secreted antigenic target-6kDa antigen fusion protein secreted by recombinant bacille Calmette\u2013Guerin","volume":"39","author":"Shi","year":"2007","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"3","key":"10.1016\/j.vaccine.2009.08.044_bib68","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1574-695X.2007.00322.x","article-title":"Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN-gamma confers effective protection against Mycobacterium tuberculosis in C57BL\/6 mice","volume":"51","author":"Xu","year":"2007","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.08.044_bib69","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-3083.2007.02048.x","article-title":"Evaluation of a new recombinant BCG which contains mycobacterial antigen ag85B-mpt64(190-198)-mtb8.4 in C57\/BL6 mice","volume":"67","author":"Qie","year":"2008","journal-title":"Scand J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.044_bib70","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00430-008-0098-x","article-title":"Evaluation of a recombinant BCG expressing antigen Ag85B and PPE protein Rv3425 from DNA segment RD11 of Mycobacterium tuberculosis in C57BL\/6 mice","volume":"198","author":"Wang","year":"2008","journal-title":"Med Microbiol Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2009.08.044_bib71","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1086\/586902","article-title":"Efficacy of recombinant bacille Calmette\u2013Guerin vaccine secreting interleukin-15\/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis","volume":"197","author":"Tang","year":"2008","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2009.08.044_bib72","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette\u2013Guerin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.vaccine.2009.08.044_bib73","doi-asserted-by":"crossref","first-page":"e3790","DOI":"10.1371\/journal.pone.0003790","article-title":"rBCG induces strong antigen-specific T cell responses in rhesus macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vector","volume":"3","author":"Magalhaes","year":"2008","journal-title":"PLoS ONE"},{"issue":"33","key":"10.1016\/j.vaccine.2009.08.044_bib74","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1016\/j.vaccine.2009.05.048","article-title":"Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.044_bib75","unstructured":"Shafferman A, Zvi A, Ariel N, Fulkerson J, Sun R, Chang R, et al., inventors. Novel recombinant BCG tuberculosis vaccine designed to elicit immune responses to Mycobacterium tuberculosis in all physiological stages of infection and disease. United States Patent Application patent 20090136534; 2009."},{"issue":"13","key":"10.1016\/j.vaccine.2009.08.044_bib76","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/0264-410X(93)90096-G","article-title":"Oral immunization with recombinant BCG induces cellular and humoral immune responses against the foreign antigen","volume":"11","author":"Lagranderie","year":"1993","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2009.08.044_bib77","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1286-4579(99)80077-X","article-title":"Cytolytic T-cell responses to human dendritic cells and macrophages infected with Mycobacterium bovis BCG and recombinant BCG secreting listeriolysin","volume":"1","author":"Conradt","year":"1999","journal-title":"Microbes Infect"},{"issue":"9","key":"10.1016\/j.vaccine.2009.08.044_bib78","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1128\/IAI.68.9.4877-4883.2000","article-title":"Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice","volume":"68","author":"Nascimento","year":"2000","journal-title":"Infect Immun"},{"issue":"15\u201316","key":"10.1016\/j.vaccine.2009.08.044_bib79","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/S0264-410X(00)00439-4","article-title":"Protective responses against experimental Mycobacterium leprae infection in mice induced by recombinant Bacillus Calmette\u2013Guerin over-producing three putative protective antigen candidates","volume":"19","author":"Ohara","year":"2001","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2009.08.044_bib80","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1365-3083.2003.01321.x","article-title":"Modulation of host immune responses by overexpression of immunodominant antigens of Mycobacterium tuberculosis in bacille Calmette\u2013Guerin","volume":"58","author":"Rao","year":"2003","journal-title":"Scand J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.08.044_bib81","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1128\/IAI.71.4.1656-1661.2003","article-title":"Virulence, immunogenicity, and protective efficacy of two recombinant Mycobacterium bovis bacillus Calmette\u2013Guerin strains expressing the antigen ESAT-6 from Mycobacterium tuberculosis","volume":"71","author":"Bao","year":"2003","journal-title":"Infect Immun"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2009.08.044_bib82","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.vaccine.2003.08.017","article-title":"Adjuvant activity of Mycobacterium bovis BCG expressing CRM197 on the immune response induced by BCG expressing tetanus toxin fragment C","volume":"22","author":"Mazzantini","year":"2004","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2009.08.044_bib83","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1128\/IAI.73.4.2190-2196.2005","article-title":"Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens","volume":"73","author":"Demangel","year":"2005","journal-title":"Infect Immun"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2009.08.044_bib84","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/j.vaccine.2005.01.057","article-title":"Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model","volume":"23","author":"Kita","year":"2005","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2009.08.044_bib85","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1139\/w05-095","article-title":"Induction of humoral immunity in response to immunization with recombinant Mycobacterium bovis BCG expressing the S1 subunit of Bordetella pertussis toxin","volume":"51","author":"Medeiros","year":"2005","journal-title":"Can J Microbiol"},{"issue":"14","key":"10.1016\/j.vaccine.2009.08.044_bib86","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1097\/00029330-200707020-00003","article-title":"Expression and immunogenicity of recombinant Mycobacterium bovis Bacillus Calmette\u2013Guerin strains secreting the antigen ESAT-6 from Mycobacterium tuberculosis in mice","volume":"120","author":"Wang","year":"2007","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"10.1016\/j.vaccine.2009.08.044_bib87","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.micinf.2007.10.010","article-title":"Neonatal immunization with a single dose of recombinant BCG expressing subunit S1 from pertussis toxin induces complete protection against Bordetella pertussis intracerebral challenge","volume":"10","author":"Nascimento","year":"2008","journal-title":"Microbes Infect"},{"issue":"11","key":"10.1016\/j.vaccine.2009.08.044_bib88","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.1128\/IAI.00434-08","article-title":"A Replication-Limited Recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for human immunodeficiency virus-positive persons is safer and more efficacious than BCG","volume":"76","author":"Tullius","year":"2008","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2009.08.044_bib89","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1139\/W08-056","article-title":"B subunit of Escherichia coli heat-labile enterotoxin as adjuvant of humoral immune response in recombinant BCG vaccination","volume":"54","author":"da Silva Ramos","year":"2008","journal-title":"Can J Microbiol"},{"issue":"24","key":"10.1016\/j.vaccine.2009.08.044_bib90","doi-asserted-by":"crossref","first-page":"11473","DOI":"10.1073\/pnas.90.24.11473","article-title":"Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette\u2013Guerin expressing the Leishmania surface proteinase gp63","volume":"90","author":"Connell","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.vaccine.2009.08.044_bib91","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.4049\/jimmunol.156.11.4309","article-title":"Neutralizing antibody responses elicited in mice immunized with recombinant bacillus Calmette\u2013Guerin producing the Schistosoma mansoni glutathione S-transferase","volume":"156","author":"Kremer","year":"1996","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.08.044_bib92","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1084\/jem.188.5.845","article-title":"Recombinant Mycobacterium bovis bacillus Calmette\u2013Guerin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies","volume":"188","author":"Matsumoto","year":"1998","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.vaccine.2009.08.044_bib93","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.1128\/IAI.66.12.5669-5676.1998","article-title":"Systemic and mucosal immune responses after intranasal administration of recombinant Mycobacterium bovis bacillus Calmette\u2013Guerin expressing glutathione S-transferase from Schistosoma haematobium","volume":"66","author":"Kremer","year":"1998","journal-title":"Infect Immun"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2009.08.044_bib94","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0264-410X(98)00255-2","article-title":"Immunogenicity of recombinant BCG producing the GRA1 antigen from Toxoplasma gondii","volume":"17","author":"Supply","year":"1999","journal-title":"Vaccine"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2009.08.044_bib95","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0264-410X(01)00382-6","article-title":"Immune response induced by recombinant BCG expressing merozoite surface antigen 2 from Plasmodium falciparum","volume":"20","author":"Zheng","year":"2001","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.044_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1383-5769(01)00094-0","article-title":"Recombinant Mycobacterium bovis BCG producing the circumsporozoite protein of Plasmodium falciparum FCC-1\/HN strain induces strong immune responses in BALB\/c mice","volume":"51","author":"Zheng","year":"2002","journal-title":"Parasitol Int"},{"issue":"3","key":"10.1016\/j.vaccine.2009.08.044_bib97","first-page":"213","article-title":"Comparative study on the immunogenicity between recombinant MS-Sj26GST vaccine and recombinant BCG-Sj26GST vaccine in Schistosoma japonicum","volume":"23","author":"Dai","year":"2003","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"issue":"17","key":"10.1016\/j.vaccine.2009.08.044_bib98","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1016\/j.vaccine.2006.01.053","article-title":"Immunogenicity of a recombinant Mycobacterium bovis bacille Calmette\u2013Guerin expressing malarial and tuberculosis epitopes","volume":"24","author":"Rapeah","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2009.08.044_bib99","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.parint.2007.04.003","article-title":"Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii","volume":"56","author":"Wang","year":"2007","journal-title":"Parasitol Int"},{"issue":"10","key":"10.1016\/j.vaccine.2009.08.044_bib100","first-page":"911","article-title":"Changes of cytokines of splenocytes in mice immunized by mix recombinant BCG-EmII\/3 and BCG-Em14-3-3 vaccine of Em","volume":"23","author":"Li","year":"2007","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2009.08.044_bib101","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.vetpar.2008.11.006","article-title":"Protective immunity of recombinant Mycobacterium bovis BCG expressing rhomboid gene against Eimeria tenella challenge","volume":"160","author":"Wang","year":"2009","journal-title":"Vet Parasitol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.044_bib102","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0378-1119(91)90587-2","article-title":"Expression of heterologous genes in Mycobacterium bovis BCG: induction of a cellular response against HIV-1 Nef protein","volume":"109","author":"Winter","year":"1991","journal-title":"Gene"},{"issue":"7","key":"10.1016\/j.vaccine.2009.08.044_bib103","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.4049\/jimmunol.150.7.3101","article-title":"Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys","volume":"150","author":"Yasutomi","year":"1993","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.08.044_bib104","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0264-410X(94)00001-4","article-title":"Recombinant BCG strains expressing the SIVmac251nef gene induce proliferative and CTL responses against nef synthetic peptides in mice","volume":"13","author":"Winter","year":"1995","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2009.08.044_bib105","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/infdis\/172.3.698","article-title":"Recombinant bacille Calmette\u2013Guerin priming against measles","volume":"172","author":"Fennelly","year":"1995","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2009.08.044_bib106","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1086\/514140","article-title":"Recombinant bacille Calmette\u2013Guerin expressing the measles virus nucleoprotein protects infant rhesus macaques from measles virus pneumonia","volume":"176","author":"Zhu","year":"1997","journal-title":"J Infect Dis"},{"issue":"22","key":"10.1016\/j.vaccine.2009.08.044_bib107","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/S0264-410X(99)00550-2","article-title":"Immune responses induced by BCG recombinant for human papillomavirus L1 and E7 proteins","volume":"18","author":"Jabbar","year":"2000","journal-title":"Vaccine"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2009.08.044_bib108","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0264-410X(01)00414-5","article-title":"Expression of the B-cell and T-cell epitopes of the rabies virus nucleoprotein in Mycobacterium bovis BCG and induction of an humoral response in mice","volume":"20","author":"da Cruz","year":"2001","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.vaccine.2009.08.044_bib109","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1016\/S0264-410X(03)00256-1","article-title":"Immunization with recombinant Calmette\u2013Guerin bacillus (BCG)-hepatitis C virus (HCV) elicits HCV-specific cytotoxic T lymphocytes in mice","volume":"21","author":"Uno-Furuta","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.044_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2004.11.026","article-title":"Humoral response and genetic stability of recombinant BCG expressing hepatitis B surface antigens","volume":"125","author":"Rezende","year":"2005","journal-title":"J Virol Methods"},{"issue":"20","key":"10.1016\/j.vaccine.2009.08.044_bib111","doi-asserted-by":"crossref","first-page":"12871","DOI":"10.1128\/JVI.79.20.12871-12879.2005","article-title":"Priming-boosting vaccination with recombinant Mycobacterium bovis bacillus Calmette\u2013Guerin and a nonreplicating vaccinia virus recombinant leads to long-lasting and effective immunity","volume":"79","author":"Ami","year":"2005","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.08.044_bib112","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1128\/JVI.79.3.1452-1462.2005","article-title":"Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette\u2013Guerin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif","volume":"79","author":"Someya","year":"2005","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.044_bib113","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.clim.2005.11.005","article-title":"Intradermal and oral immunization with recombinant Mycobacterium bovis BCG expressing the simian immunodeficiency virus Gag protein induces long-lasting, antigen-specific immune responses in guinea pigs","volume":"119","author":"Kawahara","year":"2006","journal-title":"Clin Immunol"},{"issue":"18","key":"10.1016\/j.vaccine.2009.08.044_bib114","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1016\/j.vaccine.2007.01.087","article-title":"Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine","volume":"25","author":"Dennehy","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2009.08.044_bib115","first-page":"324","article-title":"Construction of recombinant BCG bearing S1 glycoprotein of nephropathogenic IBV and study on its immunogenicity on chickens","volume":"47","author":"Bai","year":"2007","journal-title":"Wei Sheng Wu Xue Bao"},{"issue":"7","key":"10.1016\/j.vaccine.2009.08.044_bib116","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1128\/CVI.00407-06","article-title":"Recombinant bacillus Calmette\u2013Guerin elicits HIV-1 envelope-specific T lymphocytes at mucosal sites","volume":"14","author":"Yu","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.044_bib117","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.virusres.2007.03.016","article-title":"Rabbits immunised with recombinant BCG expressing the cottontail rabbit papillomavirus (CRPV) L2E7E2 genes induces regression of established papillomas","volume":"127","author":"Govan","year":"2007","journal-title":"Virus Res"},{"issue":"6","key":"10.1016\/j.vaccine.2009.08.044_bib118","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00705-008-0082-1","article-title":"A novel hepatitis C virus vaccine approach using recombinant Bacillus Calmette\u2013Guerin expressing multi-epitope antigen","volume":"153","author":"Wei","year":"2008","journal-title":"Arch Virol"},{"issue":"52","key":"10.1016\/j.vaccine.2009.08.044_bib119","doi-asserted-by":"crossref","first-page":"20822","DOI":"10.1073\/pnas.0806244105","article-title":"Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG","volume":"105","author":"Bueno","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.044_bib120","first-page":"113","article-title":"Enhancement of cell-mediated immune response in mice by whole HIV-1 gag in Mycobacterium bovis BCG as a live vaccine candidate","volume":"40","author":"Promkhatkaew","year":"2009","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"11","key":"10.1016\/j.vaccine.2009.08.044_bib121","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1128\/JVI.02544-08","article-title":"Recombinant Mycobacterium bovis BCG prime-recombinant adenovirus boost vaccination in rhesus monkeys elicits robust polyfunctional simian immunodeficiency virus-specific T-cell responses","volume":"83","author":"Cayabyab","year":"2009","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.08.044_bib122","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0022-5347(05)67417-4","article-title":"Murine IL-2 secreting recombinant bacillus Calmette\u2013Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2","volume":"164","author":"Yamada","year":"2000","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.08.044_bib123","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1440-1711.2002.01078.x","article-title":"Manipulation of immune responses to Mycobacterium bovis by vaccination with IL-2- and IL-18-secreting recombinant bacillus Calmette Guerin","volume":"80","author":"Young","year":"2002","journal-title":"Immunol Cell Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.08.044_bib124","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/00002371-200403000-00005","article-title":"Immunotherapy of experimental bladder cancer with recombinant BCG expressing interferon-gamma","volume":"27","author":"Arnold","year":"2004","journal-title":"J Immunother"},{"issue":"8","key":"10.1016\/j.vaccine.2009.08.044_bib125","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1398-9995.2005.00826.x","article-title":"Recombinant Mycobacterium bovis BCG producing IL-18 reduces IL-5 production and bronchoalveolar eosinophilia induced by an allergic reaction","volume":"60","author":"Biet","year":"2005","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.vaccine.2009.08.044_bib126","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s00262-009-0673-z","article-title":"Recombinant bacillus Calmette\u2013Guerin (BCG) expressing interferon-alpha 2B enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in vitro","volume":"58","author":"Liu","year":"2009","journal-title":"Cancer Immunol Immunother"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09012201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09012201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:16:30Z","timestamp":1759400190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09012201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":126,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0264410X09012201"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.08.044","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant Mycobacterium bovis BCG","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.08.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}